These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2474417)

  • 41. Establishment of Primary Cell Culture From Ascitic Fluid and Solid Tumor Obtained From Epithelial Ovarian Carcinoma Patients.
    Kar R; Chawla D; Gupta B; Mehndiratta M; Wadhwa N; Agarwal R
    Int J Gynecol Cancer; 2017 Nov; 27(9):2000-2005. PubMed ID: 28816710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinoembryonic antigen in ovarian cancer: correlation of concentrations in tumour tissue, cyst fluid, ascitic fluid and peripheral blood.
    Khoo SK; Hill R; Daunter B; Mackay EV
    Aust N Z J Obstet Gynaecol; 1982 May; 22(2):65-70. PubMed ID: 6958253
    [No Abstract]   [Full Text] [Related]  

  • 43. Adult granulosa cell tumor presenting as metastases to the pleural and peritoneal cavity.
    Gupta N; Rajwanshi A; Dey P; Suri V
    Diagn Cytopathol; 2012 Oct; 40(10):912-5. PubMed ID: 21618710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ascitic fluid cytology in a case of metastatic malignant mixed mesodermal tumor of the ovary.
    Silverman JF; Gardner J; Larkin EW; Finley JL; Norris HT
    Acta Cytol; 1986; 30(2):173-6. PubMed ID: 3457508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma.
    Skov RV; Bichel P
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(1):59-62. PubMed ID: 2068803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
    Zimmerman RL; Fogt F; Goonewardene S
    Cancer; 2000 Aug; 90(4):230-4. PubMed ID: 10966563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
    Roa I; Araya JC; Shiraisch T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
    Rev Med Chil; 1992 Nov; 120(11):1218-26. PubMed ID: 1340939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ascitic fluid cytology of adenosarcoma of the ovary: a case report.
    Hirakawa E; Kobayashi S; Miki H; Haba R; Saoo K; Yamakawa K; Ohkura I; Kira Y
    Diagn Cytopathol; 2001 May; 24(5):343-6. PubMed ID: 11335966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Density distribution, cytomorphologic features and immunologic characteristics of ovarian and endometrial clear cell carcinomas.
    Harłozińska A; Rabczyński J; Bar JK; Richter R
    Acta Cytol; 1990; 34(5):657-63. PubMed ID: 2220244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytology of yolk-sac tumor of the ovary in ascitic fluid. Report of a case.
    Roncalli M; Gribaudi G; Simoncelli D; Servida E
    Acta Cytol; 1988; 32(1):113-6. PubMed ID: 2447720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
    Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
    Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoglobulins reactive to carcinoembryonic antigen and their relationship to the antigen in malignant ascitic fluid of ovarian carcinoma.
    Hill R; Khoo SK; Daunter B; Silburn PA; Mackay EV
    Int J Cancer; 1982 Nov; 30(5):587-92. PubMed ID: 7152721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative cytology in ovarian carcinoma ascitic fluids.
    Kalogeraki A; Panayiotides J; Tzardi M; Tamiolakis D; Datseris G; Vlachonikolis J; Delides GS
    Anal Quant Cytol Histol; 2000 Apr; 22(2):139-42. PubMed ID: 10800615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunochemical approach to clinical cytology by demonstration of tumor markers using enzyme-labeled antibody technic].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan No Rinsho; 1986 Jul; 32(8):895-9. PubMed ID: 2427754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of cancer cells in peritoneal fluid or washing by immunocytochemical staining with monoclonal antibodies].
    Zhao Y
    Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):159-61, 189. PubMed ID: 1382925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
    Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
    Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.